CAP-1002: Phase I/II ongoing

An independent DSMB recommended continuation of the open-label, U.S. Phase I/II HOPE-Duchenne trial evaluating intracoronary infusions of CAP-1002

Read the full 183 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE